Bisphosphonates – antiresorptive drugs with analgesic effect?

Ewa Sewerynek; Michał Stuss

eISSN: 2299-0038
ISSN: 1643-8876

Menopause Review/Przegląd Menopauzalny

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

5/2007
vol. 6

Send email

Copy url:

abstract:

Bisphosphonates – antiresorptive drugs with analgesic effect?

Ewa Sewerynek

,

Michał Stuss

Przegląd Menopauzalny 2007; 5: 276–282

Online publish date: 2007/10/26

View full text Get citation

Bisphosphonates are antiresorptive drugs, which provide first-line defence against osteoporosis. Every year there are more and more reports regarding their beneficial action, targeted not only at achieving better bone mineral density but also at improving bone microarchitecture, resistance and, consequently, its quality. The final effect of the systematic use of bisphosphonates is reduction of bone fracture risk. Coexisting pain is a big problem for patients with osteoporosis. Even if the analgesic effects of bisphosphonates have not yet been completely proven, a number of patients have reported a considerable improvement in the course of the therapy. This study summarises the knowledge collected so far on bisphosphonates, with particular consideration of the possible mechanisms of their analgesic action.

keywords:

Bisphosphonates – antiresorptive drugs with analgesic effect?

Ewa Sewerynek , Michał Stuss

bisphosphonates, bone mineral density, risk of fracture, pain, osteoporosis

Ewa Sewerynek

,

Michał Stuss